Zobrazeno 1 - 10
of 121
pro vyhledávání: '"A J, ten Tije"'
Autor:
E. E. A. P. Mulder, K. de Joode, S. Litière, A. J. ten Tije, K. P. M. Suijkerbuijk, M. J. Boers-Sonderen, G. A. P. Hospers, J. W. B. de Groot, A. J. M. van den Eertwegh, M. J. B. Aarts, D. Piersma, R. S. van Rijn, E. Kapiteijn, G. Vreugdenhil, F. W. P. J. van den Berkmortel, E. Oomen-de Hoop, M. G. Franken, B. Ryll, P. Rutkowski, S. Sleijfer, J. B. A. G. Haanen, A. A. M. van der Veldt
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The introduction of programmed cell death protein 1 (PD-1) blockers (i.e. nivolumab and pembrolizumab) has significantly improved the prognosis of patients with advanced melanoma. However, the long treatment duration (i.e. two yea
Externí odkaz:
https://doaj.org/article/1258e8cfb799432884b62bfb054d74e9
Autor:
Pauline A. J. Mendelaar, Marcel Smid, Job van Riet, Lindsay Angus, Mariette Labots, Neeltje Steeghs, Mathijs P. Hendriks, Geert A. Cirkel, Johan M. van Rooijen, Albert J. Ten Tije, Martijn P. Lolkema, Edwin Cuppen, Stefan Sleijfer, John W. M. Martens, Saskia M. Wilting
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Molecular landscapes of metastatic colorectal cancers (mCRC) have often been restricted to coding regions or low numbers of patients. Here the authors present a whole-genome landscape of 429 mCRC patients, revealing the mutational impact of prior the
Externí odkaz:
https://doaj.org/article/33e7a2ece0a048d1b3f265617bf55c52
Autor:
T. M. Mackay, F. J. Smits, A. E. J. Latenstein, A. Bogte, B. A. Bonsing, H. Bos, K. Bosscha, L. A. A. Brosens, L. Hol, O. R. C. Busch, G. J. Creemers, W. L. Curvers, M. den Dulk, S. van Dieren, L. M. J. W. van Driel, S. Festen, E. J. M. van Geenen, L. G. van der Geest, D. J. A. de Groot, J. W. B. de Groot, N. Haj Mohammad, B. C. M. Haberkorn, J. T. Haver, E. van der Harst, G. J. M. Hemmink, I. H. de Hingh, C. Hoge, M. Y. V. Homs, N. C. van Huijgevoort, M. A. J. M. Jacobs, E. D. Kerver, M. S. L. Liem, M. Los, H. Lubbinge, S. A. C. Luelmo, V. E. de Meijer, L. Mekenkamp, I. Q. Molenaar, M. G. H. van Oijen, G. A. Patijn, R. Quispel, L. B. van Rijssen, T. E. H. Römkens, H. C. van Santvoort, J. M. J. Schreinemakers, H. Schut, T. Seerden, M. W. J. Stommel, A. J. ten Tije, N. G. Venneman, R. C. Verdonk, J. Verheij, F. G. I. van Vilsteren, J. de Vos-Geelen, A. Vulink, C. Wientjes, F. Wit, F. J. Wessels, B. Zonderhuis, C. H. van Werkhoven, J. E. van Hooft, C. H. J. van Eijck, J. W. Wilmink, H. W. M. van Laarhoven, M. G. Besselink, for the Dutch Pancreatic Cancer Group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-18 (2020)
Abstract Background Pancreatic cancer has a very poor prognosis. Best practices for the use of chemotherapy, enzyme replacement therapy, and biliary drainage have been identified but their implementation in daily clinical practice is often suboptimal
Externí odkaz:
https://doaj.org/article/778d6790076f4b19a04ca4000032fef5
Autor:
Anne M May, Michel W J M Wouters, Ellen Kapiteijn, John B A G Haanen, Christian U Blank, Maureen J B Aarts, Rik J Verheijden, Astrid A M van der Veldt, Marye J Boers-Sonderen, Franchette W P J van den Berkmortel, Alfonsus J M van den Eertwegh, Jan Willem B de Groot, Jacobus J M van der Hoeven, Geke A P Hospers, Djura Piersma, Rozemarijn S van Rijn, Albert J ten Tije, Gerard Vreugdenhil, Michiel C T van Zeijl, Karijn P M Suijkerbuijk
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Background Immune checkpoint inhibitor (ICI) can cause severe and sometimes fatal immune-related adverse events (irAEs). Since these irAEs mimick immunological disease, a female predominance has been speculated on. Nevertheless, no demographic or tum
Externí odkaz:
https://doaj.org/article/e9745cefbc3341ff89aba01c2bbe198f
Autor:
Pauline A. J. Mendelaar, Marcel Smid, Job van Riet, Lindsay Angus, Mariette Labots, Neeltje Steeghs, Mathijs P. Hendriks, Geert A. Cirkel, Johan M. van Rooijen, Albert J. Ten Tije, Martijn P. Lolkema, Edwin Cuppen, Stefan Sleijfer, John W. M. Martens, Saskia M. Wilting
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/7b6240df8fa849e9a92909366528f2dd
Autor:
John B. A. G. Haanen, Maureen J.B. Aarts, Michel W.J.M. Wouters, Albert J. ten Tije, Astrid A M van der Veldt, Karijn P M Suijkerbuijk, Rozemarijn S. van Rijn, Alfons J.M. van den Eertwegh, Liesbeth C. de Wreede, Ellen Kapiteijn, Geke A. P. Hospers, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, Gerard Vreugdenhil, Michiel C T van Zeijl, Jan-Willem B de Groot, Djura Piersma
Publikováno v:
International Journal of Cancer, 150(2), 317-326. Wiley-Liss Inc.
International Journal of Cancer, 150(2), 317-326. Wiley
International Journal of Cancer, 150(2), 317-326. WILEY
International Journal of Cancer, 150, 2, pp. 317-326
International Journal of Cancer, 150, 317-326
van Zeijl, M C T, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, van der Hoeven, J J M & Haanen, J B A G 2022, ' Discontinuation of anti-PD-1 monotherapy in advanced melanoma—Outcomes of daily clinical practice ', International Journal of Cancer, vol. 150, no. 2, pp. 317-326 . https://doi.org/10.1002/ijc.33800
International Journal of Cancer, 150(2), 317-326. Wiley
International Journal of Cancer, 150(2), 317-326. WILEY
International Journal of Cancer, 150, 2, pp. 317-326
International Journal of Cancer, 150, 317-326
van Zeijl, M C T, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, van der Hoeven, J J M & Haanen, J B A G 2022, ' Discontinuation of anti-PD-1 monotherapy in advanced melanoma—Outcomes of daily clinical practice ', International Journal of Cancer, vol. 150, no. 2, pp. 317-326 . https://doi.org/10.1002/ijc.33800
Contains fulltext : 287666.pdf (Publisher’s version ) (Open Access) There is no consensus on the optimal treatment duration of anti-PD-1 for advanced melanoma. The aim of our study was to gain insight into the outcomes of anti-PD-1 discontinuation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aecc11f2696429a42f3b7afc5d49f75
https://hdl.handle.net/11370/0e72933b-593e-414f-b5ab-c29ab695a795
https://hdl.handle.net/11370/0e72933b-593e-414f-b5ab-c29ab695a795
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Patient inclusion per participating medical center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac0857a031672e41b297902f8aa954f
https://doi.org/10.1158/1078-0432.22464084
https://doi.org/10.1158/1078-0432.22464084
Autor:
Karijn P.M. Suijkerbuijk, Ellen Kapiteijn, John B.A.G. Haanen, Michel W.J.M. Wouters, Michiel C.T. van Zeijl, Gerard Vreugdenhil, Astrid A.M. van der Veldt, Albert J. ten Tije, Rozemarijn S. van Rijn, Djura Piersma, Geke A. Hospers, Jacobus J.M. van der Hoeven, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Alfonsus J.M. van den Eertwegh, Franchette W.P.J. van den Berkmortel, Maureen J.B. Aarts, Christian U. Blank, Anne M. May, Rik J. Verheijden
Suppl. tab. S1 | Multivariable Cox regression of baseline factors associated with overall survival in all first-line checkpoint inhibitor treated patients Suppl. tab. S2 | Multivariable Cox regression of baseline factors associated with overall survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::742a384f917f9cb609af63491e5128a5
https://doi.org/10.1158/1078-0432.22477943.v1
https://doi.org/10.1158/1078-0432.22477943.v1
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Reasons for patients going off-protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a968ac59fcc730be5cc55219c07a5d1
https://doi.org/10.1158/1078-0432.22464078.v1
https://doi.org/10.1158/1078-0432.22464078.v1
Autor:
Ron H.J. Mathijssen, Ronald de Wit, Dana Chitu, Nelly van der Meer, Hanneke Zuetenhorst, Albert J. ten Tije, Henk van Halteren, Aart Beeker, Andries M. Bergman, Robbert J. van Alphen, Robert J. van Soest, Sander Bins, Paul Hamberg, Anne-Joy M. de Graan, Annemieke J.M. Nieuweboer
Reasons of inevaluability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f44a456a75d980de02959594fee7a8d
https://doi.org/10.1158/1078-0432.22464081.v1
https://doi.org/10.1158/1078-0432.22464081.v1